期刊文献+

培菲康与匹维溴铵治疗腹泻型肠易激综合征疗效对比研究 被引量:2

Comparison of Cure Effect of Peifeikang and Pinaverium Bromide on Diarrhea Irritable Bowel Syndrome(IBS)
下载PDF
导出
摘要 [目的]探讨肠易激综合征有效治疗途径。[方法]腹泻型肠易激综合征患者98例随机分为3组,培菲康加匹维溴胺(联合治疗)组32例;匹维溴胺组30例,培菲康组36例。[结果]联合治疗组和匹溴维胺组与培菲康组相比,腹痛改善显著(P<0.05)。联合治疗组与匹溴维胺组间差异无统计学意义(P>0.05),联合治疗组与匹溴维胺组相比,腹胀改善显著(P<0.05);匹溴维胺组和培菲康组间差异无统计学意(P>0.05)。培菲康组在改善腹泻方面比匹溴维胺组更有效(P<0.05)。[结论]匹溴维胺联合应用培菲康治疗腹泻型肠易激综合征对患者腹痛、腹泻、腹胀症状改善显著,联用培菲康可增强匹溴维胺的疗效。 [Objective]To discuss the effective method for IBS. [Method]Diarrhea IBS 98 cases were divided into 3 groups, one group 32 cases treated with Peifeikang and Pinaverium Bromide(combination treatment), one group 30 with Pinaverium Bromide, another group 36 Peifeikang. [Result]Comparing combination group and Pinaverium Bromide group with Peifeikang group, the abdomen pain was relieved markedly(P〈0.05) ; there's no statistical difference between combination group and Pinaverium Bro- mide group (P〉0.05); comparing combination group with Pinaverium Bromide group, the distension was obviously relieved(P 〈0. 05) ;there's no statistical difference between Pinaverium Bromide group and Peifeikang group(P〉 0.05). But Peifeikang group was more effective on relieving diarrhea compared with Pinaverium Bromide group (P〈0.05). [Conclusion] Pinaverium Bromide combined with Peifeikang treating diarrhea IBS can markedly relieve patients' symptoms of abdomen pain, diarrhea and distention, and reinforce the cure effect.
出处 《浙江中医药大学学报》 CAS 2008年第6期777-778,共2页 Journal of Zhejiang Chinese Medical University
关键词 肠易激综合征 腹泻 培菲康 匹溴维胺 IBS diarrhea Peifeikang Pinaverium Bromide
  • 相关文献

参考文献6

二级参考文献39

  • 1[1]Lauer GM,Walker BD.Hepatitis C virus infection.N Engl J Med 2001; 345:41-52.
  • 2[2]Alter MJ,Kruszon-Moran D,Nainan OV,McQuillan GM,Gao F,Moyer LA,Kaslow RA,Margolis HS.The prevalence of hepatitis C virus infection in the United States,1988 through 1994.N Engl J Med 1999; 341:556-562
  • 3[3]Curry MP.Hepatitis B and hepatitis C viruses in liver transplantation.Transplantation 2004; 78:955-963
  • 4[4]Vargas HE,Laskus T,Radkowski M,Wilkinson J,Balan V,Douglas DD,Harrison ME,Mulligan DC,Olden K,Adair D,Rakela J.Detection of hepatitis C virus sequences in brain tissue obtained in recurrent hepatitis C after liver transplantation.Liver Transpl 2002; 8:1014-1019
  • 5[5]Yan FM,Chen AS,Hao F,Zhao XP,Gu CH,Zhao LB,Yang DL,Hao LJ.Hepatitis C virus may infect extrahepatic tissues in patients with hepatitis C.World J Gastroenterol 2000; 6:805-811
  • 6[6]Lamelin JP,Zoulim F,Trepo C.Lymphotropism of hepatitis B and C viruses:an update and a newcomer.Int J Clin Lab Res 1995; 25:1-6
  • 7[7]Gruener NH,Jung MC,Schirren CA.Recurrent hepatitis C virus infection after liver transplantation:natural course,therapeutic approach and possible mechanisms of viral control.J Antimicrob Chemother 2004; 54:17-20
  • 8[8]Porter SB,Reddy KR.Factors that influence the severity of recurrent hepatitis C virus following liver transplantation.Clin Liver Dis 2003; 7:603-614
  • 9[9]Prieto M,Berenguer M,Rayon JM,Cordoba J,Arguello L,Carrasco D,Garcia-Herola A,Olaso V,De Juan M,Gobernado M,Mir J,Berenguer J.High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation:relationship with rejection episodes.Hepatology 1999; 29:250-256
  • 10[10]Forman LM,Lewis JD,Berlin JA,Feldman HI,Lucey MR.The association between hepatitis C infection and survival after orthotopic liver transplantation.Gastroenterology 2002; 122:889-896

共引文献415

同被引文献39

引证文献2

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部